» Articles » PMID: 225269

Cell-mediated Immunity to Varicella-zoster Virus Measured by Virus Inactivation: Mechanism and Blocking of the Reaction by Specific Antibody

Overview
Journal Infect Immun
Date 1979 Jul 1
PMID 225269
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The process whereby varicella-zoster (V-Z) virus is inactivated in vitro by immune human peripheral blood leukocytes stimulated with V-Z antigen was examined. It was found that stimulation of leukocytes by V-Z antigen, but not by other viral antigens, was required for inactivation of V-Z virus to occur. Viral inactivation could be blocked by addition of V-Z antiserum to either the stimulation phase of the reaction or the inactivation phase, further demonstrating the specificity of the reaction. In addition these blocking experiments suggested that modulation of V-Z membrane antigen by antiserum occurred with an accompanying loss of immunological recognition of virus-infected cells. Inactivation of V-Z virus in vitro in this study appeared not to be dependent upon the secretion of interferon or upon antibody-dependent cellular cytotoxicity. The specific cells required for V-Z inactivation were T lymphocytes and monocytes (macrophage precursors).

Citing Articles

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.

Malavige G, Jones L, Kamaladasa S, Wijewickrama A, Seneviratne S, Black A PLoS One. 2008; 3(11):e3789.

PMID: 19023425 PMC: 2582489. DOI: 10.1371/journal.pone.0003789.


Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system.

Bowden R, McGavren L, Hayward A, Levin M J Clin Microbiol. 1984; 20(4):696-700.

PMID: 6490855 PMC: 271414. DOI: 10.1128/jcm.20.4.696-700.1984.


Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.

Gershon A, Steinberg S Infect Immun. 1981; 33(2):507-11.

PMID: 6268546 PMC: 350728. DOI: 10.1128/iai.33.2.507-511.1981.


Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.

Rabalais G, Berkowitz F, Hayward A, Levin M Clin Exp Immunol. 1989; 75(3):381-6.

PMID: 2539281 PMC: 1541948.


Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

Gershon A, Steinberg S Infect Immun. 1979; 25(1):170-4.

PMID: 225270 PMC: 414434. DOI: 10.1128/iai.25.1.170-174.1979.

References
1.
WELLER T, WITTON H . The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro. J Exp Med. 1958; 108(6):869-90. PMC: 2136920. DOI: 10.1084/jem.108.6.869. View

2.
Ruckdeschel J, Schimpff S, Smyth A, MARDINEY Jr M . Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease. Am J Med. 1977; 62(1):77-85. DOI: 10.1016/0002-9343(77)90352-7. View

3.
Vilcek J, Yamazaki S, Havell E . Interferon induction by vesicular stomatitis virus and its role in virus replication. Infect Immun. 1977; 18(3):863-5. PMC: 421314. DOI: 10.1128/iai.18.3.863-865.1977. View

4.
Pfizenmaier K, Starzinski-Powitz A, Rollinghoff M, Falks D, Wagner H . T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature. 1977; 265(5595):630-2. DOI: 10.1038/265630a0. View

5.
Rand K, Rasmussen L, Pollard R, Arvin A, Merigan T . Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977; 296(24):1372-7. DOI: 10.1056/NEJM197706162962402. View